2026 Q3 Portfolio Activity
In 2026 Q3, Remedium Capital Partners, LLC maintained a portfolio of 8 distinct positions. The most significant new addition was Korsana Biosciences Inc, now representing 6.06% of the total fund value. They heavily accumulated shares in Damora Therapeutics Inc, increasing the position by 466.2%. Conversely, Remedium Capital Partners, LLC completely exited their position in Apogee Therapeutics Inc.
Position History
hover any row below to update
Loading…
Total Positions
8
Quarter
2026 Q3
Top Holding
SYRE (37.8%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-8 of 8
Remedium Capital Partners, LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SYRE
Spyre Therapeut...
|
Healthcare | 37.77% | 28.78% |
#1
1
Prev: #2
|
6.0 |
—
|
-303,549 | -20.7% |
P
S
|
1,160,620 | $103,329,999 |
$36.94
+169.0%
|
2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
ORKA
Oruka Therapeut...
|
Healthcare | 29.05% | 32.99% |
#2
1
Prev: #1
|
5.5 |
—
|
-611,511 | -39.1% |
P
S
|
954,150 | $79,471,154 |
$33.65
+194.9%
|
2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
N/A
Damora Therapeu...
|
|
Unknown | 15.91% | — |
#3
Prev: #—
|
8.5 |
—
|
2,045,473 | — |
NEW
|
2,045,473 | $43,527,665 | — | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
JBIO
Jade Bioscience...
|
Healthcare | 9.28% | 7.76% |
#4
1
Prev: #5
|
6.2 |
—
|
230,064 | 14.6% |
P
S
|
1,807,814 | $25,399,787 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
KRSA
Korsana Bioscie...
|
Healthcare | 6.06% | — |
#5
Prev: #—
|
6.4 |
—
|
518,500 | — |
NEW
|
518,500 | $16,592,000 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
N/A
Crescent Biopha...
|
|
Unknown | 1.93% | 1.44% |
#6
Prev: #6
|
1.8 |
—
|
no change | no change |
P
S
|
361,250 | $5,270,638 | — | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
GLTO
Damora Therapeu...
|
Healthcare | 0.00% | 11.78% |
Sold All 😨
(Was: #4) |
0.0 |
—
|
-2,045,473 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
APGE
Apogee Therapeu...
|
Healthcare | 0.00% | 17.24% |
Sold All 😨
(Was: #3) |
0.0 |
—
|
-586,691 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 |
Showing 1-8 of 8 holdings